Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing

about

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing

Item

http://www.wikidata.org/entity/Q58698883

description

scientific article published on 28 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Heterogeneous mutation pattern ...... nts parallel NGS panel testing

@en

Heterogeneous mutation pattern ...... nts parallel NGS panel testing

@nl

type

Item

label

Heterogeneous mutation pattern ...... nts parallel NGS panel testing

@en

Heterogeneous mutation pattern ...... nts parallel NGS panel testing

@nl

prefLabel

Heterogeneous mutation pattern ...... nts parallel NGS panel testing

@en

Heterogeneous mutation pattern ...... nts parallel NGS panel testing

@nl

P1476

Heterogeneous mutation pattern ...... nts parallel NGS panel testing

@en

P2093

Gang Song

http://www.w3.org/2001/XMLSchema#string

Jianfeng Xiao

http://www.w3.org/2001/XMLSchema#string

Jiatao Lou

http://www.w3.org/2001/XMLSchema#string

Lin Wang

http://www.w3.org/2001/XMLSchema#string

Qiaomei Guo

http://www.w3.org/2001/XMLSchema#string

Wenjun Yu

http://www.w3.org/2001/XMLSchema#string

Xiaomeng Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Personalized genomic analyses for cancer mutation discovery and interpretation.

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.

Tracking the Evolution of Non-Small-Cell Lung Cancer.

DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification.

Direct detection of early-stage cancers using circulating tumor DNA.

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests.

Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.

P2888

s12943-018-0875-0

P304

131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12943-018-0875-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

JianFeng Chen

Junlei Wang

P577

2018-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106385251

http://www.w3.org/2001/XMLSchema#string

P698

30153823

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

molecular medicine

P932

6114875

http://www.w3.org/2001/XMLSchema#string